Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Green, MR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 227 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Purohit, P; Dupont, S; Stevenson, M; Green, MR
      Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection

      RNA-A PUBLICATION OF THE RNA SOCIETY
    2. Jenne, A; Hartig, JS; Piganeau, N; Tauer, A; Samarsky, DA; Green, MR; Davies, J; Famulok, M
      Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technology

      NATURE BIOTECHNOLOGY
    3. Virbasius, CMA; Holstege, FC; Young, RA; Green, MR
      Promoter-specific activation defects by a novel yeast TBP mutant compromised for TFIIB interaction

      CURRENT BIOLOGY
    4. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    5. Bhaumik, SR; Green, MR
      SAGA is an essential in vivo target of the yeast acidic activator Gal4p

      GENES & DEVELOPMENT
    6. Zhang, M; Green, MR
      Identification and characterization of yUAP/Sub2p, a yeast homolog of the essential human pre-mRNA splicing factor hUAP56

      GENES & DEVELOPMENT
    7. Lima, CMSR; Sherman, CA; Brescia, FJ; Brunson, CY; Green, MR
      Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer

      ONCOLOGY-NEW YORK
    8. Reese, JC; Green, MR
      Genetic analysis of TAF68/61 reveals links to cell cycle regulators

      YEAST
    9. Breathnach, OS; Freidlin, B; Conley, B; Green, MR; Johnson, DH; Gandara, DR; O'Connell, M; Shepherd, FA; Johnson, BE
      Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results

      JOURNAL OF CLINICAL ONCOLOGY
    10. Bahadori, HR; Green, MR; Catapano, CV
      Synergistic interaction between topotecan and microtubule-interfering agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    11. Al-Malik, H; Green, MR
      Cerebral thrombosis as a complication of Crohn disease: A case report (vol32, pg 209, 2001)

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    12. Kosty, MP; Herndon, JE; Vogelzang, NJ; Kindler, HL; Green, MR
      High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study - Cancer and Leukemia Group B 9631

      LUNG CANCER
    13. Kindler, HL; Millard, F; Herndon, JE; Vogelzang, NJ; Suzuki, Y; Green, MR
      Gemcitabine for malignant mesothelioma: A phase II trial by the cancer andleukemia group B

      LUNG CANCER
    14. Lima, CMSR; Urbanic, JJ; Lal, A; Kneuper-Hall, R; Brunson, CY; Green, MR
      Beyond pancreatic cancer: Irinotecan and gemcitabine in solid tumors and hematologic malignancies

      SEMINARS IN ONCOLOGY
    15. Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK
      A novel peptide recognition mode revealed by the X-ray structure of a coreU2AF-(35)/U2AF(65) heterodimer

      CELL
    16. Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR
      Induction of apoptosis by a secreted lipocatin that is transcriptionally regulated by IL-3 deprivation

      SCIENCE
    17. Keys, RA; Green, MR
      Gene expression - The odd coupling

      NATURE
    18. Tupler, R; Perini, G; Green, MR
      Expressing the human genome

      NATURE
    19. Green, MR; Crighton, DG
      Fluid-loaded elastic plate with mean flow: point forcing and three-dimensional effects

      JOURNAL OF FLUID MECHANICS
    20. Singh, R; Banerjee, H; Green, MR
      Differential recognition of the polypyrimidine-tract by the general splicing factor U2AF(65) and the splicing repressor sex-lethal

      RNA-A PUBLICATION OF THE RNA SOCIETY
    21. Green, MR; Lima, CMR; Sherman, CA
      Radiation and chemotherapy for patients with stage III non-small cell lungcancer

      SEMINARS IN RADIATION ONCOLOGY
    22. Green, MR
      TBP-associated factors (TAF(II)s): multiple, selective transcriptional mediators in common complexes

      TRENDS IN BIOCHEMICAL SCIENCES
    23. Green, MR; Harper, M; Safa, A; Sherman, CA; Mushtaq, CM; Bahadori, H; Brescia, FJ; Lima, CMSPR
      Irinotecan in the management of patients with pancreatic cancer

      ONCOLOGY-NEW YORK
    24. Alaluf, S; Muir-Howie, H; Hu, HL; Evans, A; Green, MR
      Atmospheric oxygen accelerates the induction of a post-mitotic phenotype in human dermal fibroblasts: the key protective role of glutathione

      DIFFERENTIATION
    25. Perry, MC; Ihde, DC; Herndon, JE; Grossbard, ML; Grethein, SJ; Atkins, JN; Vokes, EE; Green, MR
      Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532

      LUNG CANCER
    26. Li, XY; Bhaumik, SR; Green, MR
      Distinct classes of yeast promoters revealed by differential TAF recruitment

      SCIENCE
    27. Jackson, AT; Bunn, A; Hutchings, LR; Kiff, FT; Richards, RW; Williams, J; Green, MR; Bateman, RH
      The generation of end group information from poly(styrene)s by means of matrix-assisted laser desorption/ionisation-collision induced dissociation

      POLYMER
    28. Tupler, R; Perini, G; Pellegrino, MA; Green, MR
      Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy (vol 96, pg 12650, 1999)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    29. Green, MR
      Eastside landmark: a history of the East Los Angeles Community Union, 1968-1993

      ECONOMIC HISTORY REVIEW
    30. Cabezas, H; Harten, PF; Green, MR
      Designing greener solvents

      CHEMICAL ENGINEERING
    31. Reilly, DM; Parslew, R; Sharpe, GR; Powell, S; Green, MR
      Inflammatory mediators in normal, sensitive and diseased skin types

      ACTA DERMATO-VENEREOLOGICA
    32. Virbasius, CMA; Wagner, S; Green, MR
      A human nuclear-localized chaperone that regulates dimerization, DNA binding, and transcriptional activity of bZIP proteins

      MOLECULAR CELL
    33. Vogelzang, NJ; Herndon, JE; Miller, A; Strauss, G; Clamon, G; Stewart, FM; Aisner, J; Lyss, A; Cooper, MR; Suzuki, Y; Green, MR
      High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase IIstudy 9234

      ANNALS OF ONCOLOGY
    34. Kan, JLC; Green, MR
      Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor

      GENES & DEVELOPMENT
    35. Clamon, G; Herndon, J; Cooper, R; Chang, AY; Rosenman, J; Green, MR
      Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the Cancer and LeukemiaGroup B and the Eastern Cooperative Oncology Group

      JOURNAL OF CLINICAL ONCOLOGY
    36. Sood, R; Green, MR; McKeever, PA; Johnstone, JMS
      Meckel's diverticulitis associated with Schistosoma mansoni

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    37. Ito, T; Muto, Y; Green, MR; Yokoyama, S
      Solution structures of the first and second RNA-binding domains of human U2 small nuclear ribonucleoprotein particle auxiliary factor (U2AF(65))

      EMBO JOURNAL
    38. Bahadori, HR; Lima, CMSR; Green, MR; Safa, AR
      Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines

      ANTICANCER RESEARCH
    39. Fossella, FV; Green, MR; Eckardt, JR; Wozniak, AJ; Socinski, MA; Murren, JR
      Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer - Discussion I

      SEMINARS IN ONCOLOGY
    40. Lima, CMSR; Eckardt, JR; Leong, SS; Sherman, CA; Perkel, JA; Putman, T; Safa, AR; Bahadori, HR; Green, MR
      Single-agent gemcitabine and gemcitabine/irinotecan combination (IrimoGem)in non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    41. Eckardt, JR; Green, MR; Gralla, RJ; Langer, CJ; Eastman, A; Socinski, MA
      Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer - Discussion II

      SEMINARS IN ONCOLOGY
    42. Green, MR
      Perspectives in thoracic cancer - Introduction

      SEMINARS IN ONCOLOGY
    43. Vokes, EE; Green, MR
      Current strategies for locoregionally advanced unresectable non-small celllung cancer

      SEMINARS IN ONCOLOGY
    44. Postmus, PE; Green, MR
      Overview of MTA in the treatment of non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    45. Green, MR
      Instabilities arising due to the interaction of a circular jet with a bounding rigid circular shell

      QUARTERLY JOURNAL OF MECHANICS AND APPLIED MATHEMATICS
    46. Wu, SP; Romfo, CM; Nilsen, TW; Green, MR
      Functional recognition of the 3 ' splice site AG by the splicing factor U2AF(35)

      NATURE
    47. Dupont, S; Sharova, N; DeHoratius, C; Virbasius, CMA; Zhu, XC; Bukrinskaya, AG; Stevenson, M; Green, MR
      A novel nuclear export activity in HIV-1 matrix protein required for viralreplication

      NATURE
    48. Li, XY; Virbasius, A; Zhu, XC; Green, MR
      Enhancement of TBP binding by activators and general transcription factors

      NATURE
    49. Tupler, R; Perini, G; Pellegrino, MA; Green, MR
      Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    50. Perini, G; Oetjen, E; Green, MR
      The hepatitis B pX protein promotes dimerization and DNA binding of cellular basic region leucine zipper proteins by targeting the conserved basic region

      JOURNAL OF BIOLOGICAL CHEMISTRY
    51. Jenkins, G; Redwood, KL; Meadows, L; Green, MR
      Effect of gel re-organization and tensional forces on alpha 2 beta 1 integrin levels in dermal fibroblasts

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    52. Leong, SS; Lima, CMR; Sherman, CA; Green, MR
      The 1997 International Staging System for non-small cell lung cancer - Have all the issues been addressed?

      CHEST
    53. Tran, YK; Bogler, O; Gorse, KM; Wieland, I; Green, MR; Newsham, IF
      A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer

      CANCER RESEARCH
    54. Kindler, HL; Belani, CP; Herndon, JE; Vogelzang, NJ; Suzuki, Y; Green, MR
      Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma - Sequential phase II trials by the cancer and leukemia group B

      CANCER
    55. Herndon, JE; Fleishman, S; Kornblith, AB; Kosty, M; Green, MR; Holland, J
      Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

      CANCER
    56. Filsell, W; Rudman, S; Jenkins, G; Green, MR
      Coordinate upregulation of tenascin C expression with degree of photodamage in human skin

      BRITISH JOURNAL OF DERMATOLOGY
    57. Krasna, MJ; Reed, CE; Nugent, WC; Olak, J; Sugarbaker, DJ; Green, MR; Kohman, LJ
      Lung cancer staging and treatment in multidisciplinary trials: Cancer and leukemia group B cooperative group approach

      ANNALS OF THORACIC SURGERY
    58. Reilly, DM; Green, MR
      Eicosanoid and cytokine levels in acute skin irritation in response to tape stripping and capsaicin

      ACTA DERMATO-VENEREOLOGICA
    59. APONE LM; VIRBASIUS CA; HOLSTEGE FCP; WANG J; YOUNG RA; GREEN MR
      BROAD, BUT NOT UNIVERSAL, TRANSCRIPTIONAL REQUIREMENT FOR YTAF(II)17,A HISTONE H3-LIKE TAF(II) PRESENT IN TFIID AND SAGA

      MOLECULAR CELL
    60. Shen, WC; Green, MR
      Analysis of selective gene activation in yeast by differential display

      METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    61. JACKSON AT; YATES HT; SCRIVENS JH; GREEN MR; BATEMAN RH
      MATRIX-ASSISTED LASER DESORPTION IONIZATION-COLLISION INDUCED DISSOCIATION OF POLY(STYRENE)/

      Journal of the American Society for Mass Spectrometry
    62. JACKSON AT; JENNINGS RCK; SCRIVENS JH; GREEN MR; BATEMAN RH
      THE CHARACTERIZATION OF COMPLEX-MIXTURES BY FIELD DESORPTION TANDEM MASS-SPECTROMETRY

      Rapid communications in mass spectrometry
    63. OGRETMEN B; BAHADORI HR; MCCAULEY MD; BOYLAN A; GREEN MR; SAFA AR
      COORDINATED OVEREXPRESSION OF THE MRP AND GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENES AND THEIR CORRELATIONS WITH DOXORUBICIN RESISTANCE IN HUMAN MESOTHELIOMA CELL-LINES AND SV40-TRANSFORMED MESOTHELIAL CELLS

      Annals of oncology
    64. LI XY; GREEN MR
      THE HIV-1 TAT CELLULAR COACTIVATOR TAT-SF1 IS A GENERAL TRANSCRIPTIONELONGATION-FACTOR

      Genes & development
    65. VOKES EE; GREEN MR
      CLINICAL-STUDIES IN NONSMALL CELL LUNG-CANCER - THE CALGB EXPERIENCE

      Cancer investigation
    66. PERRY MC; HERNDON JE; EATON WL; GREEN MR
      THORACIC RADIATION-THERAPY ADDED TO CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN UPDATE OF CANCER AND LEUKEMIA GROUP-B STUDY-8083

      Journal of clinical oncology
    67. AHLES TA; SILBERFARB PM; HERNDON J; MAURER LH; KORNBLITH AB; AISNER J; PERRY MC; EATON WL; ZACHARSKI LL; GREEN MR; HOLLAND JC
      PSYCHOLOGIC AND NEUROPSYCHOLOGIC FUNCTIONING OF PATIENTS WITH LIMITEDSMALL-CELL LUNG-CANCER TREATED WITH CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN - A STUDY BY THE CANCER AND LEUKEMIA GROUP-B

      Journal of clinical oncology
    68. GRAZIANO SL; KERN JA; HERNDON JE; TATUM A; BRISSON ML; MEMOLI V; SUGARBAKER D; SKARIN AT; KREISMAN H; GREEN MR
      ANALYSIS OF NEUROENDOCRINE MARKERS, HER2 AND CEA BEFORE AND AFTER CHEMOTHERAPY IN PATIENTS WITH STAGE IIIA NONSMALL CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY

      Lung cancer
    69. GREEN MR
      THE 'METROPOLITAN'

      Callaloo
    70. ABRATT RP; SANDLER A; CRINO L; STEWARD WP; SHEPHERD FA; GREEN MR; NGUYEN B; PETERS GJ
      COMBINED CISPLATIN AND GEMCITABINE FOR NONSMALL CELL LUNG-CANCER - INFLUENCE OF SCHEDULING ON TOXICITY AND DRUG-DELIVERY

      Seminars in oncology
    71. HOLSTEGE FCP; JENNINGS EG; WYRICK JJ; LEE TI; HENGARTNER CJ; GREEN MR; GOLUB TR; LANDER ES; YOUNG RA
      DISSECTING THE REGULATORY CIRCUITRY OF A EUKARYOTIC GENOME

      Cell (Cambridge)
    72. Shen, WC; Apone, LM; Virbasius, CMA; Li, XY; Monsalve, M; Green, MR
      Functional analysis of TFIID components

      COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
    73. WERSTUCK G; GREEN MR
      CONTROLLING GENE-EXPRESSION IN LIVING CELLS THROUGH SMALL MOLECULE-RNA INTERACTIONS

      Science
    74. APONE LM; GREEN MR
      GENE-EXPRESSION - TRANSCRIPTION SANS TBP

      Nature
    75. MARKS N; PRASAD V; BERG MJ; GREEN MR; SAITO M
      LI-3 IN CEREBELLAR NEURONS DEPENDENT ON THEIR DIFFERENTIATION( ALTERSLEVELS OF CASPASE)

      Journal of neurochemistry
    76. ALALUF S; MUIRHOWIE H; EVANS A; GREEN MR
      ATMOSPHERIC OXYGEN ACCELERATES DIFFERENTIATION OF HUMAN DERMAL FIBROBLASTS TOWARDS A POSTMITOTIC PHENOTYPE

      Journal of investigative dermatology
    77. READ J; REDWOOD K; JENKINS G; GREEN MR
      DERMAL FIBROBLASTS FROM SUN-EXPOSED AREAS GENERATE GREATER LEVELS OF MECHANICAL FORCE IN COLLAGEN GELS THAN CELLS FROM SUN-PROTECTED SITES

      Journal of investigative dermatology
    78. OGRETMEN B; BAHADORI HR; MCCAULEY MD; BOYLAN A; GREEN MR; SAFA AR
      COORDINATED OVER-EXPRESSION OF THE MRP AND GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENES, BUT NOT MDR1, CORRELATES WITH DOXORUBICIN RESISTANCE INHUMAN-MALIGNANT MESOTHELIOMA CELL-LINES

      International journal of cancer
    79. SEAL S; MCCLEAN P; HARDING M; COWARD WA; WALTERS MP; GREEN MR; WOLFE SP; LITTLEWOOD JM
      COMPARISON OF THE EFFECT OF STANDARD AND HIGH-STRENGTH PANCREATIC-ENZYMES ON FAT DIGESTION IN CHILDREN WITH CYSTIC-FIBROSIS

      Gut
    80. HERNDON JE; GREEN MR; CHAHINIAN AP; CORSON JM; SUZUKI Y; VOGELZANG NJ
      FACTORS PREDICTIVE OF SURVIVAL AMONG 337 PATIENTS WITH MESOTHELIOMA TREATED BETWEEN 1984 AND 1994 BY THE CANCER AND LEUKEMIA GROUP-B

      Chest
    81. SAMUELS BL; HERNDON JE; HARMON DC; CAREY R; AISNER J; CORSON JM; SUZUKI Y; GREEN MR; VOGELZANG NJ
      DIHYDRO-5-AZACYTIDINE AND CISPLATIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA - A PHASE-II STUDY BY THE CANCER AND LEUKEMIA GROUP-B

      Cancer
    82. BUDMAN DR; BERRY DA; CIRRINCIONE CT; HENDERSON IC; WOOD WC; WEISS RB; FERREE CR; MUSS HB; GREEN MR; NORTON L; FREI E
      DOSE AND DOSE INTENSITY AS DETERMINANTS OF OUTCOME IN THE ADJUVANT TREATMENT OF BREAST-CANCER

      Journal of the National Cancer Institute
    83. GAUR RK; MCLAUGHLIN LW; GREEN MR
      FUNCTIONAL-GROUP SUBSTITUTIONS OF THE BRANCHPOINT ADENOSINE IN A NUCLEAR PRE-MESSENGER-RNA AND A GROUP-II INTRON

      RNA
    84. MILLER AA; ROSNER GL; RATAIN MJ; HOLLIS DR; GREEN MR; SCHILSKY RL
      PHARMACOLOGY OF 21-DAY ORAL ETOPOSIDE GIVEN IN COMBINATION WITH IV CISPLATIN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-9062)

      Clinical cancer research
    85. HARVEY DJ; BATEMAN RH; GREEN MR
      HIGH-ENERGY COLLISION-INDUCED FRAGMENTATION OF COMPLEX OLIGOSACCHARIDES IONIZED BY MATRIX-ASSISTED LASER DESORPTION IONIZATION MASS-SPECTROMETRY/

      Journal of mass spectrometry.
    86. JACKSON AT; YATES HT; SCRIVENS JH; GREEN MR; BATEMAN RH
      UTILIZING MATRIX-ASSISTED LASER DESORPTION IONIZATION-COLLISION INDUCED DISSOCIATION FOR THE GENERATION OF STRUCTURAL INFORMATION FROM POLY(ALKYL METHACRYLATE)S/

      Journal of the American Society for Mass Spectrometry
    87. ZAPP ML; YOUNG DW; KUMAR A; SINGH R; BOYKIN DW; WILSON WD; GREEN MR
      MODULATION OF THE REV-RRE INTERACTION BY AROMATIC HETEROCYCLIC-COMPOUNDS

      Bioorganic & medicinal chemistry
    88. ABRATT RP; SANDLER A; CRINO L; STEWARD W; SHEPHERD F; GREEN MR; NGUYEN B
      DOSE SCHEDULING AND DRUG TOLERABILITY IN PHASE-II STUDIES OF GEMCITABINE AND CISPLATIN CHEMOTHERAPY FOR NONSMALL CELL LUNG-CANCER

      European journal of cancer
    89. KEOUGH T; LACEY MP; KETCHA MM; BATEMAN RH; GREEN MR
      ORTHOGONAL ACCELERATION SINGLE-PASS TIME-OF-FLIGHT MASS-SPECTROMETRY FOR DETERMINATION OF THE EXACT MASSES OF PRODUCT IONS FORMED IN TANDEMMASS-SPECTROMETRY EXPERIMENTS

      Rapid communications in mass spectrometry
    90. GREEN MR; APONE LM; REESE JC; SHEN W; WALKER SS
      ANALYSIS OF YEAST TAF(II) FUNCTION IN-VIVO

      The FASEB journal
    91. FLECKNER J; ZHANG M; VALCARCEL J; GREEN MR
      U2AF(65) RECRUITS A NOVEL HUMAN DEAD BOX PROTEIN REQUIRED FOR THE U2 SNRNP-BRANCHPOINT INTERACTION

      Genes & development
    92. SOMERFIELD MR; IHDE DC; PFISTER DG; BAKER S; BERNATH A; BRESCIA FJ; FONTENOT E; GREEN MR; JOHNSON DH; OLAK J; SAUSE W; SMITH TJ; STOVER D; TURRISI AT; WATERS P; WINN RJ
      CLINICAL-PRACTICE GUIDELINES FOR THE TREATMENT OF UNRESECTABLE NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    93. BURRIS HA; MOORE MJ; ANDERSEN J; GREEN MR; ROTHENBERG ML; MADIANO MR; CRIPPS MC; PORTENOY RK; STORNIOLO AM; TARASSOFF P; NELSON R; DORR FA; STEPHENS CD; VANHOFF DD
      IMPROVEMENTS IN SURVIVAL AND CLINICAL BENEFIT WITH GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREAS CANCER - A RANDOMIZED TRIAL

      Journal of clinical oncology
    94. MAURER LH; HERNDON JE; HOLLIS DR; AISNER J; CAREY RW; SKARIN AT; PERRY MC; EATON WL; ZACHARSKI LL; HAMMOND S; GREEN MR
      RANDOMIZED TRIAL OF CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN FOR LIMITED-STAGE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY

      Journal of clinical oncology
    95. KUMAR P; HERNDON J; ELIAS AD; SUGARBAKER DJ; GREEN MR
      COMPARISON OF PREOPERATIVE THORACIC RADIATION-THERAPY (TRT) TO PREOPERATIVE CHEMOTHERAPY (CT) IN SURGICALLY STAGED IIIA(N-2) NONSMALL CELL LUNG-CANCER (NSCLC) - INITIAL RESULTS OF CANCER AND LEUKEMIA GROUP-B (CALGB) PHASE-III PROTOCOL-9134

      International journal of radiation oncology, biology, physics
    96. LUIKART SD; HERNDON JE; HOLLIS DR; MACDONALD M; MAURER LH; CRAWFORD J; CLAMON GH; WRIGHT J; PERRY MC; OZER H; GREEN MR
      PHASE-I TRIAL OF ETOPOSIDE, CARBOPLATIN, AND GM-CSF IN EXTENSIVE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-8832)

      American journal of clinical oncology
    97. GREEN MR; LEPPINGTON FG
      THE INNER AND OUTER FLOW-FIELDS DUE TO A PAIR OF SPHERES MOVING UNSTEADILY THROUGH A COMPRESSIBLE FLUID - RECTILINEAR MOTION

      IMA journal of applied mathematics
    98. WU SP; GREEN MR
      IDENTIFICATION OF A HUMAN PROTEIN THAT RECOGNIZES THE 3'-SPLICE-SITE DURING THE 2ND STEP OF PRE-MESSENGER-RNA SPLICING

      EMBO journal
    99. HERNDON JE; FLEISHMAN S; KOSTY MP; GREEN MR
      A LONGITUDINAL-STUDY OF QUALITY-OF-LIFE IN ADVANCED NONSMALL CELL LUNG-CANCER - CANCER AND LEUKEMIA GROUP-B (CALGB)-8931

      Controlled clinical trials
    100. GREEN MR; BARKLEY JE
      INTENSITY OF NEOADJUVANT THERAPY IN RESECTABLE NONSMALL CELL LUNG-CANCER

      Lung cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 23:59:42